XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Total revenues $ 7,040,815 $ 25,429,855
Operating expenses    
Cost of sales and supportive services 157,738 3,225,314
Selling, general and administrative 5,675,662 7,875,773
Research and development 3,462,813 3,053,369
Total operating expenses 9,296,213 14,154,456
Operating (loss)/income (2,255,398) 11,275,399
Other income, net 1,684,983 1,942,437
(Loss)/Income before income taxes (570,415) 13,217,836
Benefit/(Provision) for income taxes 162,192 (2,940,496)
Net and comprehensive (loss)/income $ (408,223) $ 10,277,340
Basic (loss)/income per share (in dollars per share) $ (0.01) $ 0.14
Diluted (loss)/income per share (in dollars per share) $ (0.01) $ 0.14
Weighted average shares outstanding: basic (in shares) 71,427,527 71,093,653
Weighted average shares outstanding: diluted (in shares) 71,427,527 71,562,996
Product Sales and Supportive Services [Member]    
Revenues    
Total revenues $ 5,821,247 $ 23,878,677
Research and Development [Member]    
Revenues    
Total revenues $ 1,219,568 $ 1,551,178